|
• |
Representing Aetna
entities in defending a putative class
action that challenges under ERISA the
practices of Aetna’s
internal fraud investigations employed
to recover overpaid health benefits
claims and successfully moved for the
dismissal of RICO claims challenging
that practice.
|
|
• |
Representing Wyeth
Inc. entities in defending putative
class actions from direct and indirect
purchasers of the pharmaceutical product
Effexor XR®, which assert
antitrust violations arising from
Wyeth’s patents regarding Effexor XR®
and related patent litigation with
pharmaceutical companies seeking to sell
generic versions of the product.
|
|
• |
Representing insurers
and serving as liaison counsel to
insurers and brokers in defending a
putative class action asserting
antitrust and RICO claims relating to
the practice of paying contingent
commissions to brokers in both the
District Court of New Jersey and the
Court of Appeals for the Third Circuit.
|
|
• |
Representing UBS
entities and individual defendants in
defending a putative class action
brought pursuant to the PSLRA arising
out of purchases of certain
mortgage-backed assets and successfully
moved for the dismissal of the Amended
Consolidated Complaint.
|
|
• |
Representing
Aetna entities in defending a putative class
action challenging the use of certain
databases to determine “usual and
customary rates” for reimbursing plan
members for visits to out-of-network
providers.
|
|
• |
Representing
sanofi-aventis
US
entities in state-court class action
asserting that certain pharmaceutical
companies allegedly reported false and
inflated average wholesale prices for
certain types of outpatient drugs,
related to pending Multi-District
Litigation.
|
|
• |
Representing
Prudential and individual defendants in
defending a putative class action
brought pursuant to the PSLRA arising
out of a public offering of junior
subordinated notes.
|
|
• |
Representing Perdue
Farms Inc. in defending a putative class
action asserting consumer fraud
allegations relating to Perdue’s
labeling and sales of certain of its
chicken products.
|
|
• |
Representing a
variety of pharmaceutical companies as
local counsel in prosecuting or
defending patent litigation claims
arising under the Hatch-Waxman Act.
|
|
• |
Representing
Ideavillage Products in defending a
putative class action that asserted
claims of consumer fraud, unjust
enrichment, and the like relating to the
advertising, marketing, and sales of the
Kinoki Foot Pads products.
|
|
• |
Representing clients
in the snack food industry in defending
against putative class actions in the
District of New Jersey and Eastern
District of Pennsylvania based on
consumer fraud allegations that the
caloric and fat content of certain snack
foods were mislabeled.
|
|
• |
Representing life
sciences entities and serving as liaison
counsel to approximately 100
pharmaceutical, technological, and other
life sciences entities in defending
claims of patent infringement in both
the District of New Jersey and the Court
of Appeals for the Federal Circuit.
|
|
• |
Representing Mosaid
Technologies in patent litigation
regarding circuits on DRAM chips and
achieved major victory through, in part,
a landmark legal decision on
e-discovery.
|
|
• |
Representing Texas
Instruments as local counsel in patent
and antitrust litigation that resulted
in the entry of a jury verdict in excess
of $100,000,000.00 on behalf of the
client.
|
|
• |
Representing
sanofi-aventis entities in defending
qui tam litigation arising out of
the False Claims Act.
|
|
• |
Representing
directors and officers of a real estate
developer in defending claims of
consumer fraud and violations of the New
Jersey Planned Real Estate Development
Full Disclosure Act in connection with
the development, offering, and sale of
certain condominiums.
|
|
Published Decisions
|
|
• |
Pension Trust Fund
for Operating Eng’r v. Mortgage Asset
Securitization Trans., Inc.,
2011 U.S.
Dist. LEXIS 114090 (D.N.J. Sept. 29,
2011). |
|
• |
Ass’n of N.J.
Chiropractors v. Aetna, Inc.,
2011
U.S.
Dist. LEXIS 67718 (D.N.J. June 17,
2011).
|
|
• |
Ass’n of N.J.
Chiropractors v. Aetna, Inc.,
2011
U.S.
Dist. LEXIS 67718 (D.N.J. June 20,
2011). |
|
• |
TransWeb, LLC v.
3M Innovative Props. Co.,
2011
U.S.
Dist. LEXIS 59095 (D.N.J. June 1, 2011). |
|
• |
Eisai Inc. v.
sanofi-aventis U.S.,
LLC,
2011 U.S. Dist. LEXIS 128429 (D.N.J.
Nov. 7, 2011). |
|
• |
Eisai Inc. v.
sanofi-aventis U.S.,
LLC,
2011 U.S. Dist. LEXIS 128430 (D.N.J.
Nov. 7, 2011). |
|
• |
Eisai
Inc. v. sanofi-aventis U.S.,
LLC,
2011 U.S. Dist. LEXIS 128447 (D.N.J.
Nov. 7, 2011). |
|
• |
Pieczenik v.
Abbott Labs.,
2011 U.S.
Dist. LEXIS 29790 (D.N.J. Mar. 23,
2011). |
|
• |
1200 Grand Street
Condo. Assoc. v. Tarragon Corp.,
2011 Bankr. LEXIS 1001 (Bankr. D.N.J. Mar. 18,
2011). |
|
• |
Aventis Pharm., Inc. v.
Impax Labs.,
2011 U.S.
Dist. LEXIS 3824 (D.N.J. Jan. 13, 2011). |
|
• |
Aventis Pharm., Inc. v.
Impax Labs.,
2011 U.S.
Dist. LEXIS 2858 (D.N.J. Jan. 11, 2011).
|
|
• |
United States
ex rel. Piacentile v. Sanofi Synthelabo, Inc.,
2010
U.S.
Dist. LEXIS 137895 (D.N.J. Dec. 31, 2010). |
|
• |
Wyeth v. Orgenus Pharma,
2010 U.S.
Dist. LEXIS 111004 (D.N.J. Oct. 19, 2010). |
|
• |
1200 Grand Street
Condo. Assoc. v. Tarragon Corp.,
2010 Bankr. LEXIS 3515 (Bankr. D.N.J. Oct. 1,
2010). |
|
• |
Skolnick v. Tarragon Corp.,
2010 Bankr. LEXIS 6290 (Bankr. D.N.J. Sept. 27,
2010). |
|
• |
Eisai Inc. v.
sanofi-aventis U.S.,
LLC,
2010 U.S. Dist. LEXIS 94460 (D.N.J.
Sept. 20, 2010). |
|
• |
In
re Ins. Brokerage Antitrust Litig.,
618 F.3d 300 (3d Cir. 2010). |
|
• |
LLDV, L.P. v. Dinicola,
2010 U.S.
Dist. LEXIS 82078 (D.N.J. Aug. 12,
2010). |
|
• |
|
Eisai Inc. v. sanofi-aventis U.S.,
LLC,
2010 U.S. Dist. LEXIS 82291
(D.N.J. Aug. 10, 2010).
|
|
|
• |
In re N.J. Title Ins. Litig.,
2010 U.S.
Dist. LEXIS 67273 (D.N.J. July 6, 2010). |
|
• |
|
Bauer v. Prudential Fin., Inc.,
2010 U.S.
Dist. LEXIS 64384 (D.N.J. June
29, 2010).
|
|
|
• |
|
Albany Molecular Research, Inc.
v. Dr. Reddy’s Labs., Ltd.,
2010 U.S. Dist. LEXIS 59236
(D.N.J. June 14, 2010).
|
|
|
• |
Nelson v. Xacta 3000 Inc.,
2010 U.S.
Dist. LEXIS 47128 (D.N.J. May 12, 2010). |
|
• |
Schering Corp. v. Glenmark Pharms., Inc. USA,
2010 U.S.
Dist. LEXIS 38382 (D.N.J. Apr. 19,
2010). |
|
• |
|
Fritzky v. Aetna Health, Inc.,
2010 U.S.
Dist. LEXIS 27730 (D.N.J. Mar.
24, 2010).
|
|
|
• |
|
In re Ins. Brokerage Antitrust
Litig.,
374 Fed. App’x 263 (3d Cir.
2010).
|
|
|
• |
|
In re Title Ins. Litig.,
2009 U.S.
Dist. LEXIS 80582 (D.N.J. Oct.
5, 2009).
|
|
|
• |
|
Novo Nordisk v. sanofi-aventis U.S.
LLC,
2009 U.S. Dist. LEXIS 62657
(D.N.J. July 22, 2009).
|
|
|
• |
|
Schatz-Bernstein v. Keystone
Food Prods.,
2009 U.S.
Dist. LEXIS 34700 (D.N.J. Apr.
17, 2009).
|
|
|
• |
Devito v. Aetna, Inc.,
536 F. Supp. 2d 523 (D.N.J. 2008). |
|
• |
|
Novo Nordisk v. sanofi-aventis U.S.
LLC,
2008 U.S. Dist. LEXIS 12342
(D.N.J. Feb. 19, 2008).
|
|
|
• |
Appaloosa Inv., L.P.I. v. J.P. Morgan
Sec., Inc.,
398 N.J. Super. 52, 939 A.2d 257 (App.
Div. 2008). |
|
• |
Broadcom Corp. v. Qualcomm Inc.,
501 F.3d 297 (3d Cir. 2007). |
|
• |
Aventis Pharm., Inc. v. Barr Lab., Inc.,
411 F. Supp. 2d 490 (D.N.J. 2006). |
|
• |
In re Aventis Pharm., Inc.,
372 F. Supp. 2d 430 (D.N.J. 2005). |
|
• |
|
MOSAID Tech. Inc. v. Samsung
Elec. Co.,
362 F. Supp. 2d 526 (D.N.J.
2004).
|
|
|
• |
|
MOSAID Tech. Inc. v. Samsung
Elec. Co.,
348 F. Supp. 2d 595 (D.N.J.
2004).
|
|
|
• |
Di Giorgio Corp. v. Mendez and Co.,
230 F. Supp. 2d 552 (D.N.J. 2002). |
|
• |
Bio-Tech. Gen. Corp. v. Duramed Pharm.,
Inc.,
174 F. Supp. 2d 229 (D.N.J. 2001). |
|
• |
Biovail Corp. Int’l v. Hoechst
Aktiengesellschaft,
49 F. Supp. 2d 750 (D.N.J. 1999). |
|
• |
Eli Lilly and Co. v. Roussell Corp.,
23 F. Supp. 2d 460 (D.N.J. 1998). |
|
• |
Bryant v. N.J. Dept. of Transp.,
1 F. Supp. 2d 426 (D.N.J. 1998). |
|
• |
|
Bryant v. N.J. Dept. of Transp.,
998 F. Supp. 438 (D.N.J. 1998).
|
|
|
Professional Activities
|
|
• |
Essex County Representative, New Jersey Bar Association Judicial and
Prosecutorial Committee
|
|
• |
Fellow,
American Bar Foundation
|
|
• |
Trustee,
Federal Bar of the State of
New Jersey
|
|
• |
Trustee, New Jersey District Court
Historical Society
|
|
• |
Member,
Fellows of the American Bar Foundation
|
|
• |
Member,
Finance Committee, Roman Catholic
Archdiocese of Newark
|
|
• |
Chairperson,
Outside Compensation Committee;
Member, Board of Directors, Bally
Total Fitness Corporation (1996−2003)
|
|
Honors and
Awards
|
|
• |
Best Lawyers in America®,
Commercial Litigation (2007−2011)
|
|
• |
Best Lawyers in America®,
Patent Law (2011)
|
|
• |
New Jersey
Super Lawyers®,
(2007−2011)
|
|
• |
“New Jersey’s Best 50
Women in Business,”
NJBIZ Magazine
|
|
|
|
|
|
|
|
|
|